New technologies spur innovation in CAR T cell therapies.
As researchers generate innovative CAR T cell therapies for hematological and solid tumor cancers, they face many challenges throughout their development workflows. Luckily, there are many end to end solutions for CAR T cell discovery, development, and manufacturing, which enable researchers to rapidly get over technological hurdles.
Download this white paper from OXGENE to learn about solutions to common CAR T cell challenges. • Finding a target • Building a CAR and optimizing expression • Engineering and manufacturing CAR T cells
